Cell Proliferation and Differentiation By the Fbw 7 Tumor Suppressor
Cell Proliferation and Differentiation By the Fbw 7 Tumor Suppressor
批准号:
7226081
负责人:
Bruce E Clurman
金额:
$46.48万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2011-11-30
关键词:
AntibodiesB-LymphocytesBindingBiochemicalBiological AssayCell ProliferationCellsCellular biologyComplexCyclin EDataDevelopmentElementsEventExcisionExhibitsGenesGoalsHematopoiesisHematopoieticHematopoietic stem cellsIn VitroInvestigationJUN geneKnock-outKnockout MiceLeftLentivirus VectorMapsMass Spectrum AnalysisMediatingMessenger RNAModelingMusMutationMyelogenousPathway interactionsPatternPhosphopeptidesPhosphorylationPhosphorylation SiteProcessProtein IsoformsProteinsProteolysisRNA SplicingRegulationResearchResistanceRestRoleSCF(Fbw7) Ubiquitin LigaseSKP Cullin F-Box Protein LigasesSignal PathwaySignal TransductionSite-Directed MutagenesisStem cellsTissuesTumor Suppressor Proteinsc-myc Genesin vivomouse modelnotch proteinprogenitorprotein degradationprotein functionrecombinaseself-renewalsmall hairpin RNAstem
中文摘要
Fbw 7蛋白作为SCF泛素连接酶的底物识别组分起作用。FBW7
促进造血干细胞(HSC)生物学中涉及的几种蛋白质的降解,包括
我们的初步数据表明Fbw 7在HSC/祖细胞中表达,
并调节造血分化。本项目的总体目标是了解
Fbw 7通路在造血干/祖细胞增殖和分化中的作用,并确定Fbw 7通路在造血干/祖细胞增殖和分化中的作用。
在这些过程中特定的Fbw 7底物的重要性。
Fbw 7基因编码在不同亚细胞区室中起作用的三种蛋白质同种型。的
目的一的目的是检测HSC/祖细胞中Fbw 7同种型的表达和调节,
成熟的造血元件和在造血分化期间。目标二的目标是研究
通过使用两种互补策略来抑制Fbw 7在HSC/祖细胞中的功能
表情第一种方法利用shRNA介导的Fbw 7敲低来减少Fbw 7在细胞中的表达。
第二种方法需要开发条件无效的Fbw 7,
敲除小鼠,其将用于在体内将Fbw 7转染到HSC/祖细胞中。我们将使用这两个
研究Fbw 7在造血干/祖细胞中功能的策略,并确定Fbw 7在造血干/祖细胞中的作用。
Fbw 7通路在这些细胞中调节特异性底物如Myc、Notch和细胞周期蛋白E。
目的三是了解调控Fbw 7介导的Notch的机制
降解我们将首先使用生物化学方法来识别磷酸化事件,
Fbw 7的缺口降解。然后,我们将研究这一途径如何在HSC/祖细胞中被调控,
开发识别这些关键磷酸化的抗体。最后,我们将研究
Fbw 7介导的Notch降解在HSC/祖细胞中通过开发条件性“敲入”小鼠
Notch不能被Fbw 7降解,因为它不能被磷酸化。重要的是这
模型将特别损害Notch降解,同时保持Fbw 7途径的其余部分完整。
总之,本研究将提供Fbw 7在HSC/祖细胞中功能的全面研究。
英文摘要
The Fbw7 protein functions as the substrate-recognition component of SCF ubiquitin ligases. Fbw7
promotes the degradation of several proteins implicated in hematopoietic stem cell (HSC) biology, including
Myc, Notch, cyclin E, and c-Jun. Our preliminary data indicate that Fbw7 is expressed in HSCs/progenitors
and regulates hematopoietic differentiation. The overall goal of this project is to understand the role of the
Fbw7 pathway in hematopoietic stem/progenitor cell proliferation and differentiation, and to determine the
importance of specific Fbw7 substrates in these processes.
The Fbw7 gene encodes three protein isoforms that function in different subcellular compartments. The
goal of Aim One is to examine the expression and regulation of the Fbw7 isoforms in HSCs/progenitors,
mature hematopoietic elements, and during hematopoietic differentiation. The goal of Aim Two is study the
functions of Fbw7 in HSCs/progenitors by using two complementary strategies to inactivate Fbw7
expression. The first approach utilizes shRNA-mediated Fbw7 knockdown to reduce Fbw7 expression in
HSCs/progenitors in vitro, whereas the second approach entails the development of a conditional-null Fbw7
knockout mouse that will be used to inactivate Fbw7 in HSCs/progenitors in vivo. We will use these two
strategies to study Fbw7 functions in hematopoietic stem/progenitor cells, and to determine the role of the
Fbw7 pathway in regulating specific substrates such as Myc, Notch, and cyclin E in these cells.
The goal of Aim Three is to understand the mechanisms that regulate Fbw7-mediated Notch
degradation. We will initially use a biochemical approach to identify the phosphorylation events that signal
Notch degradation by Fbw7. We will than study how this pathway is regulated in HSCs/progenitors by
developing antibodies that recognize these key phosphorylation(s). Finally, we will examine the importance
of Fbw7-mediated Notch degradation in HSCs/progenitors by developing a conditional "knockin" mouse
model in which Notch cannot be degraded by Fbw7 because it cannot be phosphorylated. Importantly, this
model will specially impair Notch degradation while leaving the rest of the Fbw7 pathway intact.
Overall this research will provide a comprehensive investigation of Fbw7 function in HSCs/progenitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Fbw7 ubiquitin ligase network: normal and neoplastic functions
-
批准号:10639893
-
项目类别:
-
资助金额:$46.3万
-
财政年份:2023
-
负责人:Bruce E Clurman
-
依托单位:
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer
-
批准号:10171805
-
项目类别:
-
资助金额:$16.67万
-
财政年份:2017
-
负责人:Bruce E Clurman
-
依托单位:
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer
-
批准号:10603076
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2017
-
负责人:Bruce E Clurman
-
依托单位:
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer
-
批准号:9398810
-
项目类别:
-
资助金额:$41.53万
-
财政年份:2017
-
负责人:Bruce E Clurman
-
依托单位:
Identifying CDK4 and CDK6 substrates in cancers and cancer therapy
-
批准号:8958740
-
项目类别:
-
资助金额:$22.97万
-
财政年份:2015
-
负责人:Bruce E Clurman
-
依托单位:
CDK2 and Cancer: Mechanisms and Opportunities
-
批准号:9189712
-
项目类别:
-
资助金额:$40.98万
-
财政年份:2015
-
负责人:Bruce E Clurman
-
依托单位:
Developing Ubiquitin Ligase Agonists as Cancer Therapeutics
-
批准号:8562191
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2013
-
负责人:Bruce E Clurman
-
依托单位:
Normal and Neoplastic Regulation of Cyclin E
-
批准号:6916340
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:Bruce E Clurman
-
依托单位:
Normal and Neoplastic Regulation of Cyclin E
-
批准号:7253916
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2003
-
负责人:Bruce E Clurman
-
依托单位:
Normal and Neoplastic Regulation of Cyclin E
-
批准号:7997178
-
项目类别:
-
资助金额:$37.1万
-
财政年份:2003
-
负责人:Bruce E Clurman
-
依托单位:
Normal and Neoplastic Regulation of Cyclin E
-
批准号:8403709
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2003
-
负责人:Bruce E Clurman
-
依托单位:
Normal and Neoplastic Regulation of Cyclin E
-
批准号:7613856
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2003
-
负责人:Bruce E Clurman
-
依托单位:
Normal and Neoplastic Regulation of Cyclin E
-
批准号:6767695
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:Bruce E Clurman
-
依托单位:
Normal and Neoplastic Regulation of Cyclin E
-
批准号:8204660
-
项目类别:
-
资助金额:$37.1万
-
财政年份:2003
-
负责人:Bruce E Clurman
-
依托单位:
Normal and Neoplastic Regulation of Cyclin E
-
批准号:6677518
-
项目类别:
-
资助金额:$38.49万
-
财政年份:2003
-
负责人:Bruce E Clurman
-
依托单位:
Normal and Neoplastic Regulation of Cyclin E
-
批准号:7069493
-
项目类别:
-
资助金额:$37.59万
-
财政年份:2003
-
负责人:Bruce E Clurman
-
依托单位:
Normal and Neoplastic Regulation of Cyclin E
-
批准号:7750620
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2003
-
负责人:Bruce E Clurman
-
依托单位:
MECHANISMS OF P27KIPL-ASSOCIATED NEOPLASIA
-
批准号:6628431
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2000
-
负责人:Bruce E Clurman
-
依托单位:
Mechanisms of Cell Cycle Associated Neoplasia
-
批准号:7006935
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2000
-
负责人:Bruce E Clurman
-
依托单位:
Mechanisms of Cell Cycle Associated Neoplasia
-
批准号:7174826
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2000
-
负责人:Bruce E Clurman
-
依托单位:
海外基金